Effects on Coagulation and Fibrinolysis of Desmopressin in Patients Undergoing Total Hip Replacement

Summary

Twelve patients undergoing total hip replacement, with regional anaesthesia and with dextran infusion for plasma expansion and thromboprophylaxis, were given the vasopressin analogue desmopressin (DDAVP) or placebo in a randomized, double-blind prospective study. In controls (n = 6) we found a prolongation of the bleeding time, low factor VIII (FVIII) and von Willebrand factor (vWF) and a decrease in antithrombin III to levels known to be at risk for venous thrombosis. Desmopressin shortened postoperative bleeding time, gave an early FVIII/vWF complex increase, prevented antithrombin III from falling to critically low values and appeared to activate the fibrinolytic system, both by tPA increase and PAI-1 decrease.

Thus in the controls we found changes in both coagulation and fibrinolysis indicating a haemorrhagic diathesis as well as a risk for thromboembolism. Desmopressin induced factor changes that possibly reduce both risks.

• References

• 1 Mannucci PM. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449-55
• 2 Czer LSC, Bateman TM, Gray RJ, Raymond M, Stewart ME, Lee S, Goldfinger D, Chaux A, Matloff JM. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin. J Am Coll Cardiol 1987; 9: 1139-47
• 3 Salzman EW, Weinstein MJ, Weintraub RM, Ware JA, Thurer RL, Robertson L, Donovan A, Gaffney T, Bertele V, Troll J, Smith M, Chute LE. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. N Engl J Med 1986; 314: 1402-6
• 4 Kobrinsky NL, Letts RM, Patel LR, Israels ED, Monson RC, Schwetz N, Cheang MS. 1-desamino-8-D-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double-blinded, controlled trial. Ann Intern Med 1987; 107: 446-50
• 5 Flordal PA, Svensson J, Ljungström KG. Effects of desmopressin and dextran on coagulation and fibrinolysis in healthy volunteers. Thromb Res 1991; 62: 355-64
• 6 Flordal PA, Neander G. Blood loss in total hip replacement. A retrospective study. Arch Orthop Trauma Surg (in press)
• 7 Bergqvist D. Postoperative Thromboembolism. Springer Verlag, Berlin: 1983
• 8 Modig J, Maripuu E, Sahlstedt B. Thromboembolism following total hip replacement. A prospective investigation of 94 patients with emphasis on the efficacy of lumbar epidural anesthesia in prophylaxis. Reg Anesth 1986; 11: 72-9
• 9 Thorburn J, Louden JR, Vallance R. Spinal and general anaesthesia in total hip replacement: frequency of deep vein thrombosis. Br J Anaesth 1980; 52: 1117-21
• 10 Chin S, Abou-Madi MN, Eurin B, Witvoet J, Montagne J. Blood loss in total hip replacement: extradural v. phenoperidine analgesia. Br J Anaesth 1982; 54: 491-5
• 11 Flordal PA, Ljungström KG. Effects of high dose desmopressin and dextran on renal function and blood volume. A study in normal subjects and in patients undergoing total hip replacement. Acta Anaesthesiol Scand (in press)
• 12 Laurell C-B. Electroimmuno assay. Scand J Clin Lab Invest 1972; 29 (suppl 124) 21-37
• 13 Winer BJ. Statistical Principles in Experimental Design. Mc Graw-Hill, New York: 1971. pp 514-603
• 14 Brain Power, Inc Stat View 512+. Abacus Concepts Inc, Calabasas 1986
• 15 Paramo JA, Rocha E. Changes in coagulation and fibrinolysis after total hip replacement and their relations with deep vein thrombosis. Haemostasis 1985; 15: 345-52
• 16 Rem J, Feddersen C, Brandt MR, Kehlet H. Postoperative changes in coagulation and fibrinolysis independent of neurogenic stimuli and adrenal hormones. Br J Surg 1981; 68: 229-33
• 17 Batlle J, del Río F, López Fernández MF, Martín R, López Borrasca A. Effect of dextran on factor VIII/von Willebrand factor structure and function. Thromb Haemostas 1985; 54: 697-9
• 18 Modig J. Influence of regional anesthesia, local anesthetics and sympathicomimetics on the pathophysiology of deep vein thrombosis. Acta Chir Scand 1988; Suppl 550 119-27
• 19 Reeve EB. Steady state relations between factors X, Xa, II, IIa, antithrombin III and alpha-2 macroglobulin in thrombosis. Thromb Res 1980; 18: 19-31
• 20 Francis CW, Pellegrini VD, Marder VJ, Harris CM, Totterman S, Gabriel KR, Baughman DJ, Roemer S, Burke J, Goodman TL, Evarts CMC. Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40. J Bone Joint Surg (Am) 1989; 7 1-A 327-35
• 21 Eriksson BI, Eriksson E, Gyzander E, Teger-Nilsson AC, Risberg B. Thrombosis after hip replacement. Relationship to the fibrinolytic system. Acta Orthop Scand 1989; 60: 159-63
• 22 Ogston D. Venous Thrombosis. Causation and Prediction. Wiley, Chichester: 1987
• 23 Modig J, Malmberg P, Karlström G. Effect of epidural versus general anaesthesia on calf blood flow. Acta Anaesthesiol Scand 1980; 24: 305-9
• 24 Westermann K, Trentz O, Pretschner P, Meilmann J. Thromboembolism after hip surgery. Int Orthop 1981; 4: 253-7
• 25 Barrow SE, Heavey DJ, Jacqz E, Blair IA, Dollery CT. Des-amino-D-arginine vasopressin does not increase circulating levels of prostacyclin or thromboxane A2 during infusion in man. Thromb Haemostas 1983; 50: 622
• 26 Tangen O, Wik KO, Almqvist IAM, Arfors K-E, Hint HC. Effects of dextran on the structure and plasmin-induced lysis of human fibrin. Thromb Res 1972; 1: 487-92